Coronavirus: potential winners from the almost-pandemic
If there is one positive from the outbreak of the coronavirus – which has spread alarmingly quickly since it first emerged in China at the end of last year – it is that global healthcare systems have been alerted to the need for better contamination control.
It’s hardly surprising therefore, that the share price of Tristel (LON: TSTL), a specialist manufacturer of infection prevention and contamination control products, has climbed to new highs over recent weeks. It could be a big long-term winner from greater investment in global infection prevention. Tristel’s proprietary chlorine dioxide formulation was first developed in 1993 for the disinfection of flexible endoscopes, replacing then-gold-standard glutaraldehyde, a substance known to be toxic. Originally used in water treatment and food industries, chlorine dioxide has now been adopted as a high-level disinfectant in medical settings. Tristel’s range of products which use the formulation are now considered…